UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Oncoimmunology, 2023-12, Vol.12 (1), p.2219591-2219591

2023

Link zum Volltext

Verfügbarkeit prüfen

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells

The Journal of immunology (1950), 2017-01, Vol.198 (2), p.729-740

2017

Link zum Volltext

Verfügbarkeit prüfen

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix

Translational oncology, 2024-03, Vol.41, p.101884-101884, Article 101884

2024

Link zum Volltext

Verfügbarkeit prüfen

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

PloS one, 2020-11, Vol.15 (11), p.e0242092-e0242092

2020

Link zum Volltext

Verfügbarkeit prüfen

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Frontiers in immunology, 2019-02, Vol.10, p.79-79

2019

Link zum Volltext

Verfügbarkeit prüfen

Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation

PloS one, 2013-04, Vol.8 (4), p.e62426

2013

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy in Combination With Cytokine Treatment

Frontiers in oncology, 2019-05, Vol.9, p.367-367

2019

Link zum Volltext

Verfügbarkeit prüfen

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Frontiers in immunology, 2019-10, Vol.10, p.2393

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Frontiers in immunology, 2019-05, Vol.10, p.967-967

2019

Link zum Volltext

Verfügbarkeit prüfen

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice

Frontiers in immunology, 2018-02, Vol.9, p.290-290

2018

Link zum Volltext

Verfügbarkeit prüfen

High hydrostatic pressure in cancer immunotherapy and biomedicine

Biotechnology advances, 2018-05, Vol.36 (3), p.577-582

2018

Link zum Volltext

Verfügbarkeit prüfen

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

PloS one, 2020-01, Vol.15 (11)

2020

Link zum Volltext

Verfügbarkeit prüfen

Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy

PloS one, 2012-05, Vol.7 (5), p.e37156-e37156

2012

Link zum Volltext

Verfügbarkeit prüfen

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment

Oncotarget, 2015-06, Vol.6 (16), p.14123-14138

2015

Link zum Volltext

Verfügbarkeit prüfen

Gliadin fragments promote migration of dendritic cells

Journal of cellular and molecular medicine, 2011-04, Vol.15 (4), p.938-948

2011

Link zum Volltext

Verfügbarkeit prüfen

815 Combination with IL-15Rβγ superagonist, Nanrilkefusp alfa, enhances CAR T and BOXR T cell anti-tumor activity

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A914-A914

2023

Link zum Volltext

Verfügbarkeit prüfen

713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A808-A808

2023

Link zum Volltext

Verfügbarkeit prüfen

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients

Data in brief, 2019-08, Vol.25, p.104321-104321, Article 104321

2019

Link zum Volltext

Verfügbarkeit prüfen

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1196-A1196

2023

Link zum Volltext

Verfügbarkeit prüfen

Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients

Journal of autoimmunity, 2019-12, Vol.105, p.102294-102294, Article 102294

2019

Link zum Volltext

Verfügbarkeit prüfen

Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor βγ superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2502-2502

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents

Trends in cancer, 2022-05, Vol.8 (5), p.426-444

2022

Link zum Volltext

Verfügbarkeit prüfen

Methods to assess DC-dependent priming of T cell responses by dying cells

Methods in enzymology, 2020, Vol.632, p.55

2020

Link zum Volltext

Verfügbarkeit prüfen

Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1[beta] via TLR4/MyD88/TRIF/MAPK/NF-[kappa]B Signaling Pathway and an NLRP3 Inflammasome Activation

PloS one, 2013-04, Vol.8 (4), p.e62426

2013

Link zum Volltext

Verfügbarkeit prüfen

Correction: Heat-Induced Structural Changes Affect OVA-Antigen Processing and Reduce Allergic Response in Mouse Model of Food Allergy

PloS one, 2012-08, Vol.7 (8)

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(14)
Immunology
(11)
Dendritic Cells
(10)
Humans
(9)
Lymphocytes
(8)
Immunotherapy
(7)
Animals
(6)
Oncology
(6)
Dendritic Cells - Immunology
(5)
Female
(5)
Monocytes
(5)
Type 1 Diabetes
(5)
Autoimmune Diseases
(4)
Cancer
(4)
Diabetes Mellitus, Type 1 - Immunology
(4)
Lymphocytes T
(4)
Mice
(4)
Multidisciplinary Sciences
(4)
Science & Technology - Other Topics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation

Radiotherapy in Combination With Cytokine Treatment

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice

High hydrostatic pressure in cancer immunotherapy and biomedicine

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms

Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment

Gliadin fragments promote migration of dendritic cells

815 Combination with IL-15Rβγ superagonist, Nanrilkefusp alfa, enhances CAR T and BOXR T cell anti-tumor activity

713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients

Interim safety and efficacy results from AURELIO-03: A phase 1 dose escalation study of the IL-2/IL-15 receptor βγ superagonist SOT101 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents

Methods to assess DC-dependent priming of T cell responses by dying cells

Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1[beta] via TLR4/MyD88/TRIF/MAPK/NF-[kappa]B Signaling Pathway and an NLRP3 Inflammasome Activation

Correction: Heat-Induced Structural Changes Affect OVA-Antigen Processing and Reduce Allergic Response in Mouse Model of Food Allergy

Aktive Filter

Suchergebnisse filtern